Susan Barnes Net Worth
The estimated Net Worth of Susan K Barnes is at least $7.35 Million dollars as of 15 February 2019. Ms. Barnes owns over 11,987 units of Pacific Biosciences of California stock worth over $3,557,810 and over the last 16 years she sold PACB stock worth over $2,671,007. In addition, she makes $1,125,760 as Chief Financial Officer and Executive Vice President at Pacific Biosciences of California.
Ms. Barnes PACB stock SEC Form 4 insider trading
Susan has made over 5 trades of the Pacific Biosciences of California stock since 2005, according to the Form 4 filled with the SEC. Most recently she sold 11,987 units of PACB stock worth $85,827 on 15 February 2019.
The largest trade she’s ever made was exercising 316,990 units of Pacific Biosciences of California stock on 20 December 2018 worth over $1,356,717. On average, Susan trades about 44,329 units every 269 days since 2003. As of 15 February 2019 she still owns at least 737,370 units of Pacific Biosciences of California stock.
You can see the complete history of Ms. Barnes stock trades at the bottom of the page.
Susan Barnes biography
Susan K. Barnes serves as a Chief Financial Officer, Executive Vice President of the company. She joined us in 2010 as our Senior Vice President and Chief Financial Officer and was promoted to Executive Vice President and Chief Financial Officer in December 2010. From 1997 to 2005, she was senior vice president, finance and chief financial officer of Intuitive Surgical, Inc. Ms. Barnes served on several boards of directors of public and private companies, including Northstar Neuroscience, Inc. from February 2006 to December 2009, where she also served as Audit Committee chair, and RAE Systems Inc. from September 2004 to May 2006, where she served as chair of the Audit Committee. Ms. Barnes holds an A.B. from Bryn Mawr College and an M.B.A. from the Wharton School, University of Pennsylvania.
What is the salary of Susan Barnes?
As the Chief Financial Officer and Executive Vice President of Pacific Biosciences of California, the total compensation of Susan Barnes at Pacific Biosciences of California is $1,125,760. There are 1 executives at Pacific Biosciences of California getting paid more, with Michael Hunkapiller having the highest compensation of $1,610,870.
How old is Susan Barnes?
Susan Barnes is 65, she’s been the Chief Financial Officer and Executive Vice President of Pacific Biosciences of California since 2010. There are 5 older and 4 younger executives at Pacific Biosciences of California. The oldest executive at Pacific Biosciences of California, Inc. is Lucy Shapiro, 78, who is the Independent Director.
What’s Susan Barnes’s mailing address?
Susan’s mailing address filed with the SEC is 950 KIFER ROAD, , SUNNYVALE, CA, 94086.
Insider trading at Pacific Biosciences of California
Over the last 9 years, insiders at Pacific Biosciences of California have traded over $1,101,456 worth of Pacific Biosciences of California stock and bought 2,212,330 units worth $5,921,136 . The most active insider traders include John F Milligan, Michael Hunkapiller, and William W. Ericson. On average, Pacific Biosciences of California executives and independent directors trade stock every 72 days with the average trade being worth of $501,071. The most recent stock trade was executed by James Michael Phillips on 15 February 2019, trading 7,231 units of PACB stock currently worth $51,846.
What does Pacific Biosciences of California do?
Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
Complete history of Ms. Barnes stock trades at Intuitive Surgical and Pacific Biosciences of California
Pacific Biosciences of California executives and stock owners
Pacific Biosciences of California executives and other stock owners filed with the SEC include:
- Michael Hunkapiller, Chairman of the Board, President, Chief Executive Officer
- Susan Barnes, Chief Financial Officer, Executive Vice President
- Kathy Ordonez, Director
- James Phillips, Senior Vice President – Research and Development
- William Ericson, Lead Independent Director
- Randall Livingston, Independent Director
- Marshall Mohr, Independent Director
- John Milligan, Independent Director
- Christian Henry, Independent Director
- Lucy Shapiro, Independent Director
- David Botstein, Independent Director
- Kevin P Corcoran, SVP, Market Development
- Brook H Byers, Director
- Brian B Dow, VP and PAO
- Michael Glynn, Chief Commercial Officer
- David B Singer, Director
- Susan E Siegel, Director
- Hugh C Martin, Chairman, CEO & President
- Stephen W Turner, VP & Chief Technology Officer
